Alphatec Slides on Management Changes
Alphatec Holdings, Inc. (NASDAQ: ATEC) watched its shares slide on Monday after the company reported that it was making changes to its executive team. The main change was that Terry Rich was appointed CEO…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 183
Opthotech Craters on Missed Late-Stage Clinical Trial
Opthotech Corp. (NASDAQ: OPHT) saw its shares crater on Monday after the company reported late-stage results for its treatment of wet age-related macular degeneration (AMD). The company announced that it did not reach the…
Why Alliance Healthcare Shares Have Popped
Alliance Healthcare Services shares popped on Monday after its controlling shareholder offered to acquire all of the outstanding common shares.
Alexion Pharmaceuticals Shuffles the Deck With Recent Executive Changes
Alexion Pharmaceuticals saw its shares slide on Monday after the company reported a change in its executive team.
Achaogen Rises on Late-Stage Win
Achaogen shares saw a huge gain on Monday after the company reported positive results from a late-stage trial of its lead product candidate.
Biotech Short Interest Remains Mixed
The November 30 short interest data have been compared with the previous report, and short interest was mixed in the selected biotech stocks.
Short Sellers Back Way Off Major Pharma Stocks
The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected pharmaceutical stocks.
4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy
A series of new Jefferies reports focus on four biotech stocks that have big upside potential, regardless of the political chatter.
Clearside Biomedical Closes in on Secondary Offering
Clearside Biomedical now expects to price its 4 million shares at $9.00 per share for a secondary offering valued up to more than $41 million.
Express Scripts Thumped by Short Seller Citron Research
Around noon on Thursday, short-seller Citron Research offered some free advice to President-Elect Donald Trump: If Trump is serious about cutting prescription drug costs, go after Express Scripts.
Ohr Pharma Drops on Secondary Offering
Ohr Pharmaceutical, Inc. (NASDAQ: OHRP) is watching its shares drop on Thursday after the company announced the pricing of a secondary offering. The company intends to price 3.875 million shares at $2 per share.…
Jaguar Animal Health Gears Up for Secondary Offering
Jaguar Animal Health has filed with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering of more than 6 million shares.
Endo Sells Back Its Rights to Opioid Drug and Moves to Restructure
Shares of Endo International saw a handy gain on Thursday after the company announced that it sold back its rights to an opoid pain drug to BioDelivery Sciences International.
Recro Pharma Secondary Offering (UPDATE)
Recro Pharma intends to offer more than 5 million shares at $6.99 apiece in a secondary offering valued at roughly $40 million.
Horizon Pharma Falls on Late-Stage Miss and Discontinuation
Horizon Pharma PLC saw its shares take a big step back on Thursday after the company reported topline results from one of its late-stage trials.